Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. due to allegations of materially misleading business information being issued to the investing public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased America's Car-Mart securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2]. Group 2: Company Performance and Market Reaction - On September 4, 2025, America's Car-Mart reported a first-quarter loss of $0.69 per share, compared to a net loss of $0.15 per share in the same period the previous year [3]. - Following the release of these results, America's Car-Mart's stock experienced a decline of 18.2% on the same day [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for the number of settlements [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 [4].

Core Viewpoint - Rosen Law Firm is urging investors of WPP plc to take action before the December 8, 2025 deadline for a securities class action lawsuit related to the purchase of American Depositary Shares (ADS) during the specified class period from February 27, 2025, to July 8, 2025 [1][2]. Group 1 - Investors who purchased WPP ADSs during the class period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must act by the December 8, 2025 deadline to serve as lead plaintiff, representing other class members [3][6]. - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success and recognition in this field [4]. Group 2 - The complaint alleges that WPP's management made misleading statements about the company's media arm, concealing its inability to effectively compete and resulting in a loss of market share [5]. - The lawsuit claims that when the true state of WPP's media arm was revealed, investors suffered damages due to the misleading information previously provided [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Zions Bancorporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Zions Bancorporation may face a class action lawsuit as investors who purchased its securities could be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - The firm is preparing a class action to seek recovery of investor losses following the recent financial disclosures [2]. Group 2: Financial Disclosure and Impact - On October 15, 2025, Zions Bancorporation announced a $50 million charge-off related to a loan from its subsidiary, California Bank & Trust, citing misrepresentations and contractual defaults by borrowers [3]. - Following this announcement, Zions Bancorporation's common stock experienced a significant decline of 13.14% on October 16, 2025 [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for the number of settlements [5]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has received recognition for its attorneys' expertise [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Telix Pharmaceuticals Ltd. to secure legal counsel before the January 9, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [1][2]. Group 1: Class Action Details - The class period for the securities class action is from February 21, 2025, to August 28, 2025 [1]. - Investors who purchased Telix securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 9, 2026 [3]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Allegations Against Telix Pharmaceuticals - The lawsuit alleges that Telix's defendants made materially false and misleading statements regarding the progress of prostate cancer therapeutic candidates and the quality of its supply chain [5]. - It is claimed that these misrepresentations led to damages for investors when the true information became public [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Allegations - Nidec Corporation is facing scrutiny following a report of improper accounting practices linked to its management, which led to a significant drop in its stock price [3]. - On September 4, 2025, Nidec's American Depositary Receipts (ADRs) fell by 22.7% after the announcement of the probe into accounting issues [3]. Group 2: Class Action Information - Shareholders who purchased Nidec Corporation securities may be eligible for compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2]. - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly for more information [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026.SO WHAT: If you purchased Skye securities during the C ...

Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the Inspire Medical Systems, Inc. stock is from August 6, 2024, to August 4, 2025, inclusive [2]. - Investors who purchased common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 5, 2026 [4]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience [5]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The lawsuit alleges that Inspire Medical misrepresented key facts about its Inspire V sleep apnea device, including market demand and necessary steps for its launch [6]. - Defendants are accused of issuing materially false and misleading statements that led investors to believe in strong demand for the device, resulting in investor damages when the truth was revealed [6].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Freeport-McMoRan Inc. securities between February 15, 2022, and September 24, 2025, alleging misleading statements and safety issues at the Grasberg Block Cave mine in Indonesia [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Freeport-McMoRan did not ensure adequate safety at its Grasberg Block Cave mine, leading to heightened risks for workers [5]. - It is alleged that the company failed to disclose these risks, which included regulatory, litigation, and reputational risks, resulting in materially false and misleading statements about its business and operations [5]. - Investors are encouraged to join the class action, with the deadline to serve as lead plaintiff set for January 12, 2026 [1][3]. Group 2: Investor Guidance - Investors who purchased Freeport-McMoRan securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone [4].

Core Points - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [1] - A class action is being prepared by Rosen Law Firm to seek recovery of investor losses without any out-of-pocket fees for those who purchased Western Alliance Bancorporation securities [2] - Western Alliance Bancorporation's stock fell by 10.88% on October 16, 2025, following the disclosure of a lawsuit against Cantor Group V LLC for fraud related to collateral loans [3] Company Background - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4] - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is reminding investors of WPP plc to secure legal counsel before the December 8, 2025 deadline for a securities class action related to the purchase of American Depositary Shares (ADS) during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased WPP ADSs between February 27, 2025, and July 8, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 8, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The complaint alleges that WPP provided misleading statements about its media arm's capabilities, failing to address significant market share losses and macroeconomic challenges, which led to investor damages when the truth was revealed [5].